A Clinical Trial of Dermacorder for Detecting Malignant Skin Lesions
| Status: | Archived |
|---|---|
| Conditions: | Skin Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | October 2009 |
| End Date: | June 2010 |
A Phase I Clinical Trial of Dermacorder for Detecting Malignant Skin Lesions
The Dermacorder measures the electric field in the skin. Malignant skin lesions disrupt the
skin's normal electric field and this abnormal electric field can be detected by the
Dermacorder. Therefore the investigators are testing the hypothesis that the Dermacorder
can provide useful data to guide in the diagnosis of skin disease.
The Dermacorder is a non-invasive medical device that scans a probe over the skin about 200
microns away from it and detects the electric field in the skin using capacitative coupling.
Measurements of hundreds of malignant melanomas in mice indicated that these lesions
generate an electric field that is easily detected. One previous clinical trial at the VA
Medical Center in Hampton VA indicated an 80% reliability in predicting malignant lesions by
their electric field. We have improved the Dermacorder over the past two years by enhancing
its sensitivity and stability and must now determine if these improvements have improved its
ability to detect malignant lesions. If the Dermacorder provides a reliable diagnosis of
malignant lesions, its use could dramatically reduce the number of biopsies performed and
this would significantly improve the quality of life for hundreds of thousands of Americans
seeking the advice of dermatologists regarding suspicious lesions each year
We found this trial at
1
site
Childrens Hospital Los Angeles Children's Hospital Los Angeles is a 501(c)(3) nonprofit hospital for pediatric...
Click here to add this to my saved trials
